EP 4366832 A1 20240515 - TREATMENT FOR CRYOPYRIN ASSOCIATED PERIODIC SYNDROMES (CAPS)
Title (en)
TREATMENT FOR CRYOPYRIN ASSOCIATED PERIODIC SYNDROMES (CAPS)
Title (de)
BEHANDLUNG VON MIT KRYOPYRIN ASSOZIIERTEN PERIODISCHEN SYNDROMEN (CAPS)
Title (fr)
TRAITEMENT DES SYNDROMES PÉRIODIQUES ASSOCIÉS À LA CRYOPYRINE (CAPS)
Publication
Application
Priority
- IN 202121030625 A 20210708
- IB 2022056329 W 20220708
Abstract (en)
[origin: WO2023281455A1] Present invention relates to development of compound of formula (I) for treatment of Cryopyrin Associated Periodic Syndromes (CAPS). Specifically, the present invention provides a NLRP3 inhibitors or its pharmaceutically acceptable salt for treatment of Cryopyrin Associated Periodic Syndromes (CAPS). Invention also relates to the pharmaceutical composition comprising compound of formula (I) or its pharmaceutically acceptable salts for treatment of Cryopyrin Associated Periodic Syndromes (CAPS).
IPC 8 full level
A61P 31/18 (2006.01); C07C 311/00 (2006.01); C07D 205/04 (2006.01)
CPC (source: EP)
A61P 31/18 (2018.01); C07D 207/08 (2013.01); C07D 233/60 (2013.01); C07D 277/26 (2013.01); C07D 307/64 (2013.01); C07D 333/34 (2013.01); C07D 471/04 (2013.01)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2023281455 A1 20230112; AU 2022305809 A1 20240201; CA 3226058 A1 20230112; CN 117940126 A 20240426; EP 4366832 A1 20240515
DOCDB simple family (application)
IB 2022056329 W 20220708; AU 2022305809 A 20220708; CA 3226058 A 20220708; CN 202280059495 A 20220708; EP 22837147 A 20220708